These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21574207)

  • 1. Methods of the pharmacological imaging of the cannabinoid system (PhICS) study: towards understanding the role of the brain endocannabinoid system in human cognition.
    van Hell HH; Bossong MG; Jager G; Kahn RS; Ramsey NF
    Int J Methods Psychiatr Res; 2011 Mar; 20(1):10-27. PubMed ID: 21574207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endocannabinoid system and emotional processing: a pharmacological fMRI study with ∆9-tetrahydrocannabinol.
    Bossong MG; van Hell HH; Jager G; Kahn RS; Ramsey NF; Jansma JM
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1687-97. PubMed ID: 23928295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for involvement of the insula in the psychotropic effects of THC in humans: a double-blind, randomized pharmacological MRI study.
    van Hell HH; Bossong MG; Jager G; Kristo G; van Osch MJ; Zelaya F; Kahn RS; Ramsey NF
    Int J Neuropsychopharmacol; 2011 Nov; 14(10):1377-88. PubMed ID: 21489346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Δ9-tetrahydrocannabinol administration on human encoding and recall memory function: a pharmacological FMRI study.
    Bossong MG; Jager G; van Hell HH; Zuurman L; Jansma JM; Mehta MA; van Gerven JM; Kahn RS; Ramsey NF
    J Cogn Neurosci; 2012 Mar; 24(3):588-99. PubMed ID: 22066583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the endocannabinoid system in reward processing in the human brain.
    van Hell HH; Jager G; Bossong MG; Brouwer A; Jansma JM; Zuurman L; van Gerven J; Kahn RS; Ramsey NF
    Psychopharmacology (Berl); 2012 Feb; 219(4):981-90. PubMed ID: 21822593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia.
    Suplita RL; Eisenstein SA; Neely MH; Moise AM; Hohmann AG
    Neuropharmacology; 2008 Jan; 54(1):161-71. PubMed ID: 17714742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of ∆9-tetrahydrocannabinol (THC) on resting state brain function and their modulation by COMT genotype.
    Bossong MG; van Hell HH; Schubart CD; van Saane W; Iseger TA; Jager G; van Osch MJP; Jansma JM; Kahn RS; Boks MP; Ramsey NF
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):766-776. PubMed ID: 30975584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
    Fusar-Poli P; Crippa JA; Bhattacharyya S; Borgwardt SJ; Allen P; Martin-Santos R; Seal M; Surguladze SA; O'Carrol C; Atakan Z; Zuardi AW; McGuire PK
    Arch Gen Psychiatry; 2009 Jan; 66(1):95-105. PubMed ID: 19124693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid system involvement in brain reward processes related to drug abuse.
    Solinas M; Yasar S; Goldberg SR
    Pharmacol Res; 2007 Nov; 56(5):393-405. PubMed ID: 17936009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endocannabinoid system in mental diseases.
    Manzanares J; Urigüen L; Rubio G; Palomo T
    Neurotox Res; 2004; 6(3):213-24. PubMed ID: 15325960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Default mode network in the effects of Δ9-Tetrahydrocannabinol (THC) on human executive function.
    Bossong MG; Jansma JM; van Hell HH; Jager G; Kahn RS; Ramsey NF
    PLoS One; 2013; 8(7):e70074. PubMed ID: 23936144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of low doses of delta-9 tetrahydrocannabinol on reinforcement processing in the risky decision-making of young healthy adults.
    Rogers RD; Wakeley J; Robson PJ; Bhagwagar Z; Makela P
    Neuropsychopharmacology; 2007 Feb; 32(2):417-28. PubMed ID: 17006433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manipulating brain connectivity with δ⁹-tetrahydrocannabinol: a pharmacological resting state FMRI study.
    Klumpers LE; Cole DM; Khalili-Mahani N; Soeter RP; Te Beek ET; Rombouts SA; van Gerven JM
    Neuroimage; 2012 Nov; 63(3):1701-11. PubMed ID: 22885247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
    González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
    Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC).
    Bossong MG; Jansma JM; Bhattacharyya S; Ramsey NF
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():53-69. PubMed ID: 24380726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Δ
    Silveira MM; Adams WK; Morena M; Hill MN; Winstanley CA
    J Psychiatry Neurosci; 2017 Mar; 42(2):131-138. PubMed ID: 28245177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid Modulation of Frontolimbic Activation and Connectivity During Volitional Regulation of Negative Affect.
    Gorka SM; Phan KL; Lyons M; Mori S; Angstadt M; Rabinak CA
    Neuropsychopharmacology; 2016 Jun; 41(7):1888-96. PubMed ID: 26647971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia.
    Vigano D; Guidali C; Petrosino S; Realini N; Rubino T; Di Marzo V; Parolaro D
    Int J Neuropsychopharmacol; 2009 Jun; 12(5):599-614. PubMed ID: 18789179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of endocannabinoid neurotransmission modulators on brain stimulation reward.
    Vlachou S; Nomikos GG; Panagis G
    Psychopharmacology (Berl); 2006 Oct; 188(3):293-305. PubMed ID: 16953388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.